Associate value strategy and payer engagement direct

Department :CETA (Cardiovascular and Emerging Therapeutic Areas) Do you want to work for an organization that has a strong purpose towards driving change to defeat diabetes, obesity and other serious chronic diseases such as cardiovascular, MASH, rare blood and rare endocrine diseases? If so, you could be the right person to join our Commercial GBS team. Apply today and join us for a life:changing career. About the department The Commercial GBS department is responsible for creating insights to launch a product, Market intel, Forecasting, Multichannel customer engagement planning, Global Brand Strategy and Tactics. Comprising of Project Management, Brand Management, Brand Communications, Life cycle Management of a product. The Commercial: Global Business Services (GBS) unit is responsible for driving deliverables for multiple Corporate Vice President (CVP) areas within Commercial and Corporate Affairs, including Marketing, Market Access, Commercial Planning and Commercial Operations across multiple therapeutic areas. The Commercial and Corporate Affairs unit also supports BioPharma global marketing for Haemophilia and growth disorders. The Position Accountable for defining and executing the access strategy for an upcoming launch and key pipeline assets: Coordinating with regions and affiliates, Developing unbranded and branded payer value story, Reimbursement dossier, Defining value and opportunity, inputting into payer evidence strategy, and providing direction on pipeline assets. Accountable for executing and refining the HTA strategy for key launch assets and engaging with regions and affiliates to drive best:in:class product launches. Accountable for launch preparation activities on payer and value communication activities in the market access therapy area teams, supporting the development of strategies and associated tools. Asset evaluation and planning on early assets and developing deep experience, knowledge and skills that can be of use to the wider market access team. Evaluation of size of opportunity, market value drivers as well as the policy, competitive and reimbursement landscape. Use strategic thinking on HTA and reimbursement strategy, and map submission requirements and market access barriers across key markets. Alignment with other functions on access and additional data requirements. : Drive launch preparation excellence in liaison with regions and affiliates and become therapeutic and brand experts while relying on deep technical expertise from CoEs. : Initiate and develop target access profile, market access strategy and payer value story for the asset. : Drive market access input for pipeline planning to support and impact key decision making fora in Novo Nordisk. : Drive early strategic thinking on HTA and reimbursement strategy in liaison with regions and strategic markets and become therapeutic and brand expert. : Independence and Decision Making. : Innovation and Change. Qualifications : An academic background in a relevant field (life sciences, economics, public health science, or similar) : Minimum of 9 years of experience in value strategy, value communication or health economics and health outcomes research, ideally within pharmaceutical industry or consultancy. : Advanced level competencies in: : Healthcare policy and system insight. : Product and therapeutic area knowledge. : Value message development and communication. : Business and industry insight. : Communicating with impact. : Setting direction and strategy. : Driving Performance. : Personal leadership. : Stakeholder relationship. Working at Novo Nordisk Novo Nordisk is its people. We know that life is anything but linear and balancing what is important at different stages of our career is never easy. That s why we make room for diverse life situations, always putting people first. We value our employees for the unique skills they bring to the table, an